Cigna (CI)
NYSEHealth CareMedical - Healthcare PlansSnapshot 2026-09-04
$282.52-1.31%
Close 2026-09-04 · 1-day change
NYSEHealth CareMedical - Healthcare PlansSnapshot 2026-09-04
QuarterlyIQ Insights · CI
How strong the business is — where it ranks within its sector on capital efficiency and cash generation, and how well management has been executing.
How this business ranks within health care on a research-validated quality screen. As of 2026-09-04.
The screen ranks CI against its sector on four durable signals: share dilution, return on capital, free-cash-flow yield, and FCF margin. Historically the highest-quality names tended toward better typical outcomes and fewer bad years over multi-year holds (strongest at three years, modest at one), and that pattern showed up even before the price moved. It characterizes business quality, not price direction.
Each leg is a sector-relative percentile (higher is better); 4 of 4 legs were available for this name. The composite is built from these four; the raw value follows each percentile for context.
A forward quality tilt, not a price prediction, and context for your own research rather than a recommendation. Not investment advice.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 2 of the last 3 quarter-over-quarter moves. Historically, Health Care names rated strong grew net income 53% of the time over the next year (vs 41% for the rest of the cohort, n=9986).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A guidance track record builds as the company issues and delivers on guidance.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Continue to grow adjusted income from operations through diversified portfolio and operational efficiency.
Stated as a priority in 7 of last 7 quarters. Adjusted income from operations per share guidance increased from at least $29.50 in 2024-Q4 to at least $30.45 in 2026-Q2. Actual adjusted income from operations was $2.1 billion or $7.78 per share in 2026-Q2, showing delivering trajectory consistent with management's stated growth priority.
“2026 outlook for adjusted income from operations increased to at least $30.45 per share”
“2026 outlook for adjusted income from operations increased to at least $30.35 per share”
“2026 adjusted income from operations projected to be at least $30.25 per share”
“Reaffirms 2025 outlook for adjusted income from operations of at least $29.60 per share”
“Reaffirms 2025 outlook for adjusted income from operations of at least $29.60 per share”
“2025 adjusted income from operations increased to at least $29.60 per share”
“2025 adjusted income from operations projected to be at least $29.50 per share”
Focus on growing Cigna Healthcare adjusted income from operations and managing medical care ratio.
Stated as a priority in 7 of last 7 quarters. Cigna Healthcare adjusted income from operations pre-tax target increased from at least $4.1 billion in 2024-Q4 to at least $4.55 billion in 2026-Q2. Actual segment operating income grew from $1.094 billion in 2025-Q2 to $1.276 billion in 2026-Q2 (+17%). Medical Care Ratio guidance remains stable at 83.7% to 84.7%. The trajectory shows delivering progress toward the income target.
“Cigna Healthcare Adjusted Income from Operations, Pre-Tax at least $4.55 billion; Medical Care Ratio 83.7% to 84.7%”
Drive growth in Evernorth Health Services segment adjusted income from operations through specialty and pharmacy benefit services.
Stated as a priority in 7 of last 7 quarters. Evernorth Health Services adjusted revenues grew 6% from 57.8B in 2025-Q2 to 61.5B in 2026-Q2, while adjusted income from operations pre-tax declined 2% from $1.696B to $1.663B. The 2026 target of at least $6.9B is slightly below 2024-Q4's $7.0B guidance. The trajectory shows mixed delivery with revenue growth but slight income decline.
“Evernorth Health Services second quarter 2026 adjusted revenues increased 6% and adjusted income from operations pre-tax decreased 2%”
Maintain disciplined SG&A expense ratio and improve operating efficiency to support profitability.
Stated as a priority in 5 of last 5 quarters. SG&A expense ratio improved from 5.1% in 2025-Q2 to 4.8% in 2026-Q2, reflecting improved operating efficiency. The consistent focus on expense management is delivering measurable cost discipline.
“SG&A expense ratio was 4.8% for second quarter 2026, compared to 5.1% in second quarter 2025”
Cigna aims to achieve an adjusted revenue of approximately $280 billion for the full year 2026.
Over the trailing year it converted 2.50x of net income into operating cash flow. Historically, Health Care names rated robust grew net income 55% of the time over the next year (vs 45% for the rest of the cohort, n=2490).
Not enough signal yet.
Not enough signal to read sensitivity to the US dollar, the broad stock market, real (inflation-adjusted) rates, long-term interest rates, Fed net liquidity (low R² over the window).
18 material management or governance events in the past 24 months, led by M&A activity. Historically, Health Care names rated neutral grew net income 53% of the time over the next year (vs 49% for the rest of the cohort, n=5275).
Not investment advice. As of 2026-09-04.
“Cigna Healthcare Adjusted Income from Operations, Pre-Tax at least $4.525 billion; Medical Care Ratio 83.7% to 84.7%”
“2026 Cigna Healthcare Adjusted Income from Operations, Pre-Tax at least $4.5 billion”
“Reaffirms 2025 Cigna Healthcare Adjusted Income from Operations, Pre-Tax at least $4.125 billion”
“Reaffirms 2025 Cigna Healthcare Adjusted Income from Operations, Pre-Tax at least $4.125 billion”
“2025 Cigna Healthcare Adjusted Income from Operations, Pre-Tax at least $4.125 billion”
“2025 Cigna Healthcare Adjusted Income from Operations, Pre-Tax at least $4.1 billion”
“Evernorth Health Services first quarter 2026 adjusted revenues increased 9% and adjusted income from operations pre-tax increased 2%”
“2026 Evernorth Adjusted Income from Operations, Pre-Tax at least $6.9 billion”
“Reaffirms 2025 Evernorth Adjusted Income from Operations, Pre-Tax at least $7.2 billion”
“Reaffirms 2025 Evernorth Adjusted Income from Operations, Pre-Tax at least $7.2 billion”
“2025 Evernorth Adjusted Income from Operations, Pre-Tax at least $7.2 billion”
“2025 Evernorth Adjusted Income from Operations, Pre-Tax at least $7.0 billion”
“SG&A expense ratio was 5.4% for first quarter 2026, compared to 6.4% in first quarter 2025”
“SG&A expense ratio was 5.0% for fourth quarter 2025, compared to 5.9% in fourth quarter 2024”
“SG&A expense ratio was 4.8% for third quarter 2025, compared to 5.6% in third quarter 2024”
“SG&A expense ratio was 5.1% for second quarter 2025, compared to 6.1% in second quarter 2024”